Guizhou Bailing (002424.SZ) announced, recently, the China Drug Administration (“State Drug Administration”)...
Zhitong Finance App News, Guizhou Bailing (002424.SZ) announced that recently, the China Drug Administration (“State Drug Administration”) website published the “Notice on Protected Varieties of Traditional Chinese Medicines (No. 16) (No. 47 of 2024)”. According to the provisions of the “Regulations on the Protection of Chinese Medicines”, Yindan Xinnangtong Softgel produced by Guizhou Bailing Enterprise Group Pharmaceutical Co., Ltd. was approved as the first grade 2 protected variety of traditional Chinese medicine. The protection period is: ZYB2072024003.
According to reports, Yindan XinnaoTong Softgel is the company's core exclusive product, a National Basic Drug Catalogue product and a National Medical Insurance Catalogue Class B product. The main functions are: activate blood circulation, relieve gas pain, and stagnate digestion. It is used for chest paralysis caused by gas stagnation and blood stasis, such as chest pain, chest tightness, shortness of breath, palpitations, etc.; coronary heart disease, angina pectoris, hyperlipidemia, and cerebral arteriosclerosis; stroke and sequelae of stroke see the above symptoms.